These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report. Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022 [TBL] [Abstract][Full Text] [Related]
4. Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature. Milan Manani S; Virzì GM; Giuliani A; Clementi A; Brocca A; Dissegna D; Martino F; d''Amore ESG; Ronco C Nephron; 2017; 136(3):245-253. PubMed ID: 28419995 [TBL] [Abstract][Full Text] [Related]
5. Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation. Noris M; Remuzzi G Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):704-12. PubMed ID: 24076560 [TBL] [Abstract][Full Text] [Related]
6. [Genetics of aHUS and transplant recurrence]. Bresin E G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479051 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Weitz M; Amon O; Bassler D; Koenigsrainer A; Nadalin S Pediatr Nephrol; 2011 Aug; 26(8):1325-9. PubMed ID: 21556717 [TBL] [Abstract][Full Text] [Related]
8. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363 [TBL] [Abstract][Full Text] [Related]
9. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Zuber J; Le Quintrec M; Krid S; Bertoye C; Gueutin V; Lahoche A; Heyne N; Ardissino G; Chatelet V; Noël LH; Hourmant M; Niaudet P; Frémeaux-Bacchi V; Rondeau E; Legendre C; Loirat C; Am J Transplant; 2012 Dec; 12(12):3337-54. PubMed ID: 22958221 [TBL] [Abstract][Full Text] [Related]
10. Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. Zuber J; Le Quintrec M; Morris H; Frémeaux-Bacchi V; Loirat C; Legendre C Transplant Rev (Orlando); 2013 Oct; 27(4):117-25. PubMed ID: 23937869 [TBL] [Abstract][Full Text] [Related]
11. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report. Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy after kidney transplantation. Noris M; Remuzzi G Am J Transplant; 2010 Jul; 10(7):1517-23. PubMed ID: 20642678 [TBL] [Abstract][Full Text] [Related]
13. Posttransplant recurrence of atypical hemolytic uremic syndrome. Valoti E; Alberti M; Noris M J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880 [TBL] [Abstract][Full Text] [Related]
14. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. Vondrák K; Seeman T Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469 [TBL] [Abstract][Full Text] [Related]
15. Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients. Raina R; Chauvin A; Fox K; Kesav N; Ascha M; Vachharajani TJ; Krishnappa V Ann Transplant; 2018 Sep; 23():631-638. PubMed ID: 30190449 [TBL] [Abstract][Full Text] [Related]